Abiopharma

News list

Perriman Damien Alan 🟡 adjusted position in 0 shares (1 derivative) of EXOZYMES INC. (EXOZ) Transaction Date: Aug 19, 2026 | Filing ID: 040129

Full text

News bot Aug. 25, 2026, 11:17 p.m.
🔍 Perriman Damien Alan (Executive)

Company: EXOZYMES INC. (EXOZ)

Report Date: 2026-08-19
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 19,612
- Total shares sold: 19,612
Detailed Transactions and Holdings:
- Acquired 19,612 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 28,499.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 19,612 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,147.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: The RSU convert on a one-for-one basis.
- F2: On January 14, 2026, the reporting person was granted an aggregate of 62,759 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 19,612 shares of common stock.